Michelle S. Yau

Michelle S. Yau

Auto-generated profile, based on publicly available information

Michelle S. Yau

Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
MYMichelle S. Yau
Michelle S. Yau
LYLaura M. Yerges‐Armstrong
Laura M. Yerges‐Armstrong
YLYoufang Liu
Youfang Liu
CLCora E. Lewis
Cora E. Lewis
DDDavid J. Duggan
David J. Duggan
RJRebecca D. Jackson
Rebecca D. Jackson

3 August 2023 in Arthritis & Rheumatology
Verified
Journal Article
Open access
JZJie Zheng
Jie Zheng
EWEleanor Wheeler
Eleanor Wheeler
MPMaik Pietzner
Maik Pietzner
TATill F. M. Andlauer
Till F. M. Andlauer
MYMichelle S. Yau
Michelle S. Yau
JTJonathan H. Tobias
Jonathan H. Tobias
Objective: In this study, we aimed to establish the causal effects of lowering sclerostin, target of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors.Methods: A genome‐wide association study meta‐analysis was performed of circulating sclerostin levels in 33,961 European individuals. Mendelian randomization (MR) was used to predict the causal effects of sclerostin lowering on 15 atherosclerosis‐related diseases and risk factors.Results: We found that 18 conditionally independent variants were associated with circulating sclerostin. Of these, 1 cis signal in SOST and 3 trans signals in B4GALNT3, RIN3, and SERPINA1 regions showed directionally opposite signals for sclerostin levels and estimated bone mineral density. Variants with these 4 regions were selected as genetic instruments. MR using 5 correlated cis‐SNPs suggested that lower sclerostin increased the risk of type 2 diabetes mellitus (DM) (odds ratio [OR] 1.32 [95% confidence interval (95% CI) 1.03–1.69]) and myocardial infarction (MI) (OR 1.35 [95% CI 1.01–1.79]); sclerostin lowering was also suggested to increase the extent of coronary artery calcification (CAC) (β = 0.24 [95% CI 0.02–0.45]). MR using both cis and trans instruments suggested that lower sclerostin increased hypertension risk (OR 1.09 [95% CI 1.04–1.15]), but otherwise had attenuated effects.Conclusion: This study provides genetic evidence to suggest that lower levels of sclerostin may increase the risk of hypertension, type 2 DM, MI, and the extent of CAC. Taken together, these findings underscore the requirement for strategies to mitigate potential adverse effects of romosozumab treatment on atherosclerosis and its related risk factors. image

25 July 2016 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
MYMichelle S Yau
Michelle S Yau
SDSerkalem Demissie
Serkalem Demissie
YZYanhua Zhou
Yanhua Zhou
DADennis E Anderson
Dennis E Anderson
ALAmanda L Lorbergs
Amanda L Lorbergs
ESElizabeth J Samelson
Elizabeth J Samelson
Hyperkyphosis is a common spinal disorder in older adults, characterized by excessive forward curvature of the thoracic spine and adverse health outcomes. The etiology of hyperkyphosis has not been firmly established, but may be related to changes that occur with aging in the vertebrae, discs, joints, and muscles, which function as a unit to support the spine. Determining the contribution of genetics to thoracic spine curvature and the degree of genetic sharing among co‐occurring measures of spine health may provide insight into the etiology of hyperkyphosis. The purpose of our study was to estimate heritability of thoracic spine curvature using T4–T12 kyphosis (Cobb) angle and genetic correlations between thoracic spine curvature and vertebral fracture, intervertebral disc height narrowing, facet joint osteoarthritis (OA), lumbar spine volumetric bone mineral density (vBMD), and paraspinal muscle area and density, which were all assessed from computed tomography (CT) images. Participants included 2063 women and men in the second and third generation offspring of the original cohort of the Framingham Study. Heritability of kyphosis angle, adjusted for age, sex, and weight, was 54% (95% confidence interval [CI], 43% to 64%). We found moderate genetic correlations between kyphosis angle and paraspinal muscle area (G, –0.46; 95% CI, –0.67 to –0.26), vertebral fracture (G, 0.39; 95% CI, 0.18 to 0.61), vBMD (G, –0.23; 95% CI, –0.41 to –0.04), and paraspinal muscle density (G, –0.22; 95% CI, –0.48 to 0.03). Genetic correlations between kyphosis angle and disc height narrowing (G, 0.17; 95% CI, –0.05 to 0.38) and facet joint OA (G, 0.05; 95% CI, –0.15 to 0.24) were low. Thoracic spine curvature may be heritable and share genetic factors with other age‐related spine traits including trunk muscle size, vertebral fracture, and bone mineral density. © 2016 American Society for Bone and Mineral Research.

1 November 2018 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
ARA.M. Rathbun
A.M. Rathbun
MSM D Shardell
M D Shardell
ESE.A. Stuart
E.A. Stuart
MYM.S. Yau
M.S. Yau
JGJ.J. Gallo
J.J. Gallo
MHM.C. Hochberg
M.C. Hochberg

15 September 2017 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
YLYoufang Liu
Youfang Liu
MYMichelle S. Yau
Michelle S. Yau
LYLaura M. Yerges-Armstrong
Laura M. Yerges-Armstrong
DDDavid J. Duggan
David J. Duggan
JRJordan B. Renner
Jordan B. Renner
JJJoanne M. Jordan
Joanne M. Jordan
Objective.: The etiology of knee osteoarthritis (OA), the most common form of arthritis, is complex and may differ by race or ethnicity. In recent years, genetic studies have identified many genetic variants associated with OA, but nearly all the studies were conducted in European whites and Asian Americans. Few studies have focused on the genetics of knee OA in African Americans.Methods.: We performed a genome-wide association study of radiographic knee OA in 1217 African Americans from 2 North American cohort studies: 590 subjects from the Johnston County Osteoarthritis Project and 627 subjects from the Osteoarthritis Initiative. Analyses were conducted in each cohort separately and combined in an inverse variance fixed effects metaanalysis, which were then included in pathway analyses. We additionally tested 12 single-nucleotide polymorphisms robustly associated with OA in European white populations for association in African Americans.Results.: We identified a genome-wide significant variant inLINC01006(minor allele frequency 12%; p = 4.11 × 10−9) that is less common in European white populations (minor allele frequency < 3%). Five other independent loci reached suggestive significance (p < 1 × 10−6). In pathway analyses, dorsal/ventral neural tube patterning and iron ion transport pathways were significantly associated with knee OA in African Americans (false discovery rate < 0.05). We found no evidence that previously reported OA susceptibility variants in European whites were associated with knee OA in African Americans.Conclusion.: These results highlight differences in the genetic architecture of knee OA between African American and European whites. This finding underscores the need to include more diverse populations in OA genetics studies.

29 November 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
MYMichelle S Yau
Michelle S Yau
AKAllison L Kuipers
Allison L Kuipers
RPRyan Price
Ryan Price
ANAude Nicolas
Aude Nicolas
STSalman M Tajuddin
Salman M Tajuddin
DKDouglas P Kiel
Douglas P Kiel
Genetic studies of bone mineral density (BMD) largely have been conducted in European populations. We therefore conducted a meta-analysis of six independent African ancestry cohorts to determine whether previously reported BMD loci identified in European populations were transferable to African ancestry populations. We included nearly 5000 individuals with both genetic data and assessments of BMD. Genotype imputation was conducted using the 1000G reference panel. We assessed single-nucleotide polymorphism (SNP) associations with femoral neck and lumbar spine BMD in each cohort separately, then combined results in fixed effects (or random effects if study heterogeneity was high, I2 index >60) inverse variance weighted meta-analyses. In secondary analyses, we conducted locus-based analyses of rare variants using SKAT-O. Mean age ranged from 12 to 68 years. One cohort included only men and another cohort included only women; the proportion of women in the other four cohorts ranged from 52% to 63%. Of 56 BMD loci tested, one locus, 6q25 (C6orf97, p = 8.87 × 10−4), was associated with lumbar spine BMD and two loci, 7q21 (SLC25A13, p = 2.84 × 10−4) and 7q31 (WNT16, p = 2.96 × 10−5), were associated with femoral neck BMD. Effects were in the same direction as previously reported in European ancestry studies and met a Bonferroni-adjusted p value threshold, the criteria for transferability to African ancestry populations. We also found associations that met locus-specific Bonferroni-adjusted p value thresholds in 11q13 (LRP5, p < 2.23 × 10−4), 11q14 (DCDC5, p < 5.35 × 10−5), and 17p13 (SMG6, p < 6.78 × 10−5) that were not tagged by European ancestry index SNPs. Rare single-nucleotide variants in AKAP11 (p = 2.32 × 10−2), MBL2 (p = 4.09 × 10−2), MEPE (p = 3.15 × 10−2), SLC25A13 (p = 3.03 × 10−2), STARD3NL (p = 3.35 × 10−2), and TNFRSF11A (p = 3.18 × 10−3) were also associated with BMD. The majority of known BMD loci were not transferable. Larger genetic studies of BMD in African ancestry populations will be needed to overcome limitations in statistical power and to identify both other loci that are transferable across populations and novel population-specific variants. © 2020 American Society for Bone and Mineral Research (ASBMR).